How have advancements in genomics contributed to cancer research?
The advent of next-generation sequencing (NGS) has been pivotal in cancer research. NGS allows for comprehensive analysis of multiple genes simultaneously, identifying mutations, copy number variations, and other genomic alterations. This has led to the discovery of novel cancer drivers and potential therapeutic targets. Projects like The Cancer Genome Atlas (TCGA) have provided invaluable data, advancing our understanding of cancer biology.
